Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116949024B reveals mutant enzyme boosting conversion. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN118421578A reveals high-efficiency carbonyl reductase for Montelukast intermediate. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel patent CN115873002B offers eco-friendly Remdesivir intermediate synthesis. Reduces waste, improves scalability for reliable pharmaceutical intermediate supply chains.
Patent CN103773822B reveals streamlined Simvastatin production reducing steps and solvents for supply chain efficiency.
Patent CN101314574B reveals a green aqueous method for acylated enamines using phosphotungstic acid, offering significant cost reduction and scalability for pharmaceutical intermediates.
Patent CN110467537B reveals a streamlined 6-step synthesis for L-p-hydroxyphenylglycine, offering significant cost reduction and yield improvements for antibiotic manufacturers.
Novel synthesis of Sacubitril intermediate via Cu-catalyzed coupling. Reduces cost, improves yield, scalable process for heart failure drug manufacturing.
Patent CN102994403A details a novel whole-cell biocatalytic route for (R)-2-hydroxy-4-phenylbutyric acid ethyl ester, offering superior stereoselectivity and cost efficiency for pharmaceutical manufacturing.
Novel polyionic liquid catalyst enhances yield and reduces waste for phenylpyruvic acid production offering supply chain stability and cost efficiency.
Patent CN1754963A details a solvent-free enzymatic route for pyroglutamic acid esters, offering high purity and cost-effective manufacturing for personal care suppliers.
Patent CN103539820A details a high-yield route for hexaphenoxycyclotriphosphazene. Achieve >99% purity and reduced waste for flame retardant manufacturing.
Discover the patented immobilized catalyst method for N,N-diallyl-5-methoxytryptamine hydrochloride. Achieve high purity and cost efficiency in pharmaceutical intermediate manufacturing.
Patent CN105348063A reveals a novel synthesis method for Paeonol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110003110B reveals a green photocatalytic route for aryl beta-aminoketones, offering cost reduction and mild conditions for pharmaceutical manufacturing.
Patent CN116082335A reveals a convergent synthesis for diaryl ethers using cesium salts, offering superior yields and eliminating heavy metal contaminants for reliable API manufacturing.
Patent CN108752232B details a green photocatalytic method for alpha-quaternary amino acids using CO2, offering safer alternatives to toxic Strecker reactions for pharma supply chains.
Patent CN104178540B reveals a high-yield E. coli biocatalysis route for Ademetionine, offering superior purity and streamlined manufacturing for global supply chains.
Patent CN115385909A details a novel Pd/Cu method for imidazophenanthridines, offering mild conditions and high purity for pharmaceutical intermediates.
Novel patent method for 2-hydroxyl 3 6-dichlorobenzoic acid reduces pressure requirements and enhances supply chain reliability for agrochemical manufacturers.
Patent CN104220406A reveals novel nickel catalysis for hydroxyphenylcyclohexanol. Delivers high purity, reduced costs, and scalable supply chain solutions for global pharmaceutical manufacturers.